Dr. Mohammed Sayeedur Rahman's lab at the University of Maryland Baltimore focuses on understanding how Rickettsia bacteria invade and survive within human cells. These bacteria can cause serious diseases, so the lab aims to uncover their strategies for manipulating the immune response to enhance their survival. By studying these interactions, the lab hopes to identify new approaches for preventing and treating rickettsial infections.

Dr. Philip D. King's lab at the University of Michigan focuses on understanding how a specific protein, RASA1, regulates blood vessel development. They study how mutations in this protein can lead to serious vascular malformations in the brain, especially in children. By exploring the molecular mechanisms behind these conditions, the lab aims to find ways to prevent and treat such disorders.

Dr. Xudong Li's research lab focuses on understanding how certain cellular processes affect the function and fitness of regulatory T cells, which are essential for maintaining a healthy immune response. The lab particularly investigates the role of heme synthesis, an important biological process, in controlling these T cells' abilities to prevent autoimmune diseases. By studying the effects of a specific enzyme on Treg cells, the goal is to develop new therapies that could enhance the body's natural defenses against autoimmune disorders.

Dr. Lalit K Beura's lab at Brown University focuses on understanding how specific immune cells called CD8 T lymphocytes protect the female reproductive tract from viral infections. By investigating how these cells develop and maintain their protective functions, the lab aims to improve strategies for vaccine development against viral diseases affecting this important area of the body. The research combines advanced techniques like single-cell RNA sequencing and in vitro organoid systems to explore the complex biology of immune responses.

Dr. Jacob E. Kohlmeier's lab at Emory University focuses on understanding how T cells and innate immune responses protect against respiratory viruses like SARS-CoV-2 and influenza. The research investigates how memory T cells in the respiratory tract recognize viruses and how the immune system can be trained to respond better to respiratory infections. The findings aim to enhance vaccine designs for better immunity against viral infections and to understand the dynamics of immune responses to respiratory viruses.

Dr. Katy Rezvani's lab focuses on developing innovative therapies for patients with T cell malignancies, which are difficult to treat using traditional methods. They are pioneering the use of CAR-engineered natural killer (NK) cells as a safer and more effective alternative to CAR-T cell therapies. The lab is currently conducting clinical trials to evaluate these CAR-NK cells and uses advanced techniques like genome-wide CRISPR screening to understand how to overcome treatment resistance in these cancers.

Dr. Charles M. Rice's research lab focuses on viral infections, particularly hepatitis B and various RNA viruses, including coronaviruses. The lab seeks to understand how these viruses interact with host cells, the mechanisms by which the immune system responds to these infections, and how viral pathogenesis occurs at the cellular level. By employing advanced technologies such as RNA sequencing and single-cell analysis, the lab aims to uncover new therapeutic strategies and improve our understanding of viral diseases.

Dr. Anthony R. Richardson's lab at the University of Pittsburgh focuses on understanding how certain bacterial skin pathogens can resist the toxic effects of naturally occurring molecules called polyamines. By researching the mechanisms behind polyamine toxicity and resistance in Methicillin-Resistant Staphylococcus aureus (MRSA) and Streptococcus pyogenes, the lab aims to discover new ways to create effective treatments for infections caused by these dangerous bacteria.

Professor Shinji Makino leads a research lab at the University of Texas Med Br Galveston focused on understanding the Rift Valley fever virus, which can cause serious diseases like hemorrhagic fever in humans and livestock. The lab investigates how the virus's RNA is packaged, which is crucial for developing antiviral drugs and vaccines. Their work aims to prevent outbreaks by elucidating the viral mechanisms that could aid in public health strategies against this and similar viruses.

Dr. Lucio Comai's research lab focuses on discovering new small molecule drugs for treating myotonic dystrophy type 1 (DM1), a serious genetic disorder. The lab employs innovative RNA-based screening methods to identify compounds that can effectively target and modulate disease-causing RNA, ultimately aiming to improve the lives of patients suffering from this debilitating condition. By leveraging advanced techniques and a diverse library of potential drugs, the lab is making strides in finding effective therapies where few options currently exist.

The lab led by Dr. Lijun Rong at the University of Illinois at Chicago focuses on developing new antiviral therapies for Ebola viruses. They are working on optimizing small molecule inhibitors that could potentially treat or prevent infections caused by these highly dangerous viruses. Through innovative drug design and rigorous testing in animal models, the lab aims to provide effective options for combating Ebola virus disease.

Dr. Susan R. Ross's lab at the University of Illinois at Chicago focuses on understanding how mammals' immune responses can limit retroviral infections, such as those caused by murine leukemia virus (MLV). The research explores the mechanisms by which host proteins, particularly the APOBEC3 family, interact with viral processes like reverse transcription, to help inform potential therapies for curing or preventing diseases caused by HIV and other retroviruses. This is achieved through innovative mouse models and advanced molecular techniques.

Dr. Sue Ellen Crawford's lab at Baylor College of Medicine focuses on understanding how rotavirus (RV) infection influences the metabolism of host cells, particularly related to lipid accumulation and degradation of certain proteins. The lab studies the mechanisms by which RV reprograms cellular pathways to enhance its replication and cause severe gastrointestinal issues, especially in young children. Their research aims to uncover reasons behind the life-threatening nature of RV infections and explore potential therapeutic approaches.

Dr. Namita Rout's lab focuses on understanding how chronic HIV infection affects gut health and inflammation. By studying immune cells and microbes in the gut, the lab aims to identify mechanisms behind gut dysfunction and explore new treatments to restore gut barrier integrity. This research could lead to improved health for people living with HIV and other inflammatory diseases.

Dr. Eric J. Rubin's lab at Harvard University focuses on understanding and addressing the challenges posed by non-tuberculous mycobacteria (NTMs), which are responsible for difficult-to-treat chronic infections. The lab investigates the molecular mechanisms that lead to inherent drug resistance in these pathogens and aims to identify new strategies to enhance the effectiveness of existing antibiotics and develop novel treatment options. By utilizing advanced genetic techniques and culture models, the team seeks to uncover potential therapeutic targets that could facilitate better management of NTM infections.

Dr. Brian David Rudd's lab focuses on understanding how the immune system, particularly T cells, develops and functions from infancy to adulthood. By studying lymph node responses to infections, the lab aims to create a detailed map of T cell activation and location throughout different life stages. This research can lead to better vaccines and immunotherapies that are tailored to enhance immunity, especially in early life.

David Z Rudner's lab at Harvard Medical School studies bacteria, particularly a type called Bacillus subtilis. They focus on how these bacteria grow, differentiate, and how they handle their chromosomes and cell walls during these processes. Understanding these fundamental mechanisms may lead to new treatments for bacterial infections and insights into cancer-related cell division failures.

Dr. Daniel James Salamango's lab explores the mechanisms behind HIV persistence, particularly focusing on how the HIV protein Vpr affects myeloid cells, like macrophages. They aim to understand how Vpr-induced changes in the cell's genetic material can help the virus survive in these cells, which could lead to new treatments for HIV. The findings could also contribute to the broader goal of finding a cure for HIV infection.

Dr. Denise M Monack's lab at Stanford University focuses on understanding how Salmonella bacteria survive and persist within the host's immune system. They study the interactions between Salmonella and immune cells, particularly macrophages and eosinophils, which play crucial roles in the bacteria's ability to cause disease. By investigating the mechanisms of bacterial persistence in lymph nodes and exploring factors that influence immune responses, the lab aims to identify new strategies for preventing and treating Salmonella infections.

Dr. Neal Mathew Alto's lab focuses on understanding how pathogenic bacteria, particularly Salmonella Typhimurium, evade the host's immune systems. They investigate the roles of specific bacterial proteins that coordinate the bacteria's division and survival within host cells. By studying these interactions, the lab aims to identify new strategies for developing drugs to combat infections caused by these bacteria.